Compare Citius Pharmaceuticals Inc (CTXR) vs Northrop Grumman Corporation (NOC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citius Pharmaceuticals Inc vs Northrop Grumman Corporation — how do they compare? Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M), while Northrop Grumman Corporation trades at $574.85 (market cap $81.78B). The key difference: Northrop Grumman Corporation is far larger — about 4087× Citius Pharmaceuticals Inc's market cap, and Northrop Grumman Corporation pays a 1.63% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| CTXR | NOC | |
|---|---|---|
Market Cap | $20.01M | $81.78B |
Sector | Health | Industrials |
52-Week High | $1.82 | $768.02 |
52-Week Low | $0.48 | $496.02 |
Enterprise Value | $16.23M | $95.77B |
Dividend Yield | — | 1.63% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →About Northrop Grumman Corporation
Northrop Grumman is a defense contractor that is diversified across short-cycle and long-cycle businesses. The firm's segments include aeronautics, mission systems, defense services, and space systems. The company's aerospace segment creates the fuselage for the massive F-35 program and produces various piloted and autonomous flight systems. Mission systems creates a variety of sensors and processors for defense hardware. The defense systems segment is a long-range missile manufacturer. Finally, the company's space systems segment produces various space structures, sensors, and satellites.
Read more on NOC →
